# ITM11 Expanded Access Program

> **NCT07497984** · — · AVAILABLE · sponsor: **ITM Solucin GmbH**

## Conditions studied

- Meningioma

## Interventions

- **DRUG:** ITM-11

## Key facts

- **NCT ID:** NCT07497984
- **Lead sponsor:** ITM Solucin GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2026-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07497984

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07497984, "ITM11 Expanded Access Program". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07497984. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*